A panel of nine neutralizing monoclonal antibodies was used to analyse the antigenic properties of 188 plaquepurified type 3 poliovirus strains from 17 faecal specimens, derived from eight people during a 2 month observation period. Most poliovirus specimens consisted of a mixture of antigenically distinct variants and the composition of the mixture was found to change between sequential specimens in many individuals, indicating antigenic evolution. Thirty-five strains representing different antigenic patterns were selected for partial sequencing of genomic RNA. Mutations leading to amino acid substitutions, as well as silent mutations, were seen at and close to the known antigenic sites. The frequency of silent mutations was used to estimate the evolutionary potential of the virus. The largest difference in silent changes between strains isolated from one person was 0.8 %, which corresponds to a minimum of about 60 mutations per genome within a period of 3 weeks. The observed incidence of silent mutations between isolates from different persons was usually between 0-8 and 2%. These figures agree with the previously reported overall mutation rates of poliovirus, determined by other methods.
Introduction
The mutation rate of RNA viruses is known to be high (Holland et al., 1982; Domingo et al., 1985) , which allows for great adaptability and rapid evolution in the presence of selection mechanisms. Consequently, extreme heterogeneity of viral populations within a given outbreak, or even in a single virus isolate, have been demonstrated in several studies (Batschelet et al., 1976; Domingo et al., 1978; Kew et al., 1981; Hahn et al., 1986) .
During an epidemic, nucleotide substitutions of 1 to 2% per year for wild strains of poliovirus have been suggested, based on 01igonucleotide mapping (Nottay et al., 1981) . By the same method similar rates of base substitutions of the Sabin vaccine strains have been observed during virus passage in one or two individuals . Genetic and antigenic evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee has also been reported ).
An outbreak of poliomyelitis with widespread circulation of wild poliovirus type 3 throughout the country was discovered in Finland between August 1984 and January 1985 . Finland had been free of poliomyelitis since 1964, as the result of a high coverage immunization programme with the inactivated poliovirus vaccine (Lapinleimu, 1984) . The genetic and antigenic properties of the poliovirus type 3 isolated during the epidemic differed from previously characterized wild and vaccine strains (Magrath et al., 1986; Kinnunen & Hovi, 1989) . Antigenic drift of the epidemic strain was documented in some individuals and cocirculation of several antigenic variants was seen (Huovilainen et al., 1988) .
In order to study the extent of molecular variation and the rate of evolution we isolated and plaque-purified virus strains directly from sequential faecal specimens from eight excretors and analysed them with monoclonal antibodies (MAbs) and by partial RNA sequencing. Most clinical specimens turned out to consist of mixtures of different variants. Very often rapid evolution took place between sequential specimens and amino acid substitutions were seen, mainly at the known antigenic sites.
Primer extension sequencing. The viral RNA was sequenced by the dideoxynucleotide chain termination method, as described by Huovilainen et al. (1988) . Synthetic oligonucleotide primers were purchased from the Department of Medical Chemistry, University of Helsinki, Finland. The five primers used were targeted to sequences 1554-ACCAACAACAGTGCCA-1569, 2086-ACACACACTGGGCTG-GATCCC-2106, 2820-GTGCAGTTGCGCCGGA-2835, 3213-AAT-GATCACAACCCCA-3228
and 3396-AATAAAGCTGTTTACA-3411. Selection of the primer sequences was based on the published sequence of a representative strain of the outbreak (Hughes et al., 1986) .
Results

Multitude of var&nts
Altogether 188 plaque-purified virus strains from 19 faecal specimens were analysedwith a panel of nine neutralizing MAbs, all but one directed against the Sabin strain of type 3 poliovirus. MAb 879 did not neutralize any strain and MAb 842, raised against a representative strain of the outbreak, neutralized only 29 strains, all derived from two individuals. All other MAbs were able to neutralize some, but not all, strains from most specimens and a large number of different neutralization patterns were seen (Table 1) . The number of different variants may be even greater than is shown in Table 1 , since the range of variation in the neutralization titres (16 to 2048) is ignored and some of the strains were not tested with all MAbs. On the other hand, the four most common variants made up half of the 188 strains tested.
Antigenic variation within specimens
Specimens derived from one of the eight people could not be evaluated for antigenic variation because they each yielded only one plaque per specimen. In 13 out of the 17 remaining specimens antigenic variation between the individual strains derived from a given specimen was demonstrated ( Table 2 ). The four specimens appearing homogeneous in these tests were from people whose 16.
strains, with respect to a given MAb, the result obtained with the regular isolate did not correspond to the majority of tested plaque-purified strains (Table 3) .
Antigenic evolution within one person
When antigenic properties of plaque-purified strains of sequential specimens from the same person were compared the antigenic evolution at the virus population level, i.e. a change in the composition of the mixture of variants, was seen in many cases. Several patterns of change were seen. In some cases we found in the later specimens enrichment of strains that were neutralized by more MAbs than those isolated from the earlier specimens (not shown). This is in agreement with the apparent 'countercurrent' antigenic drift of evolution discussed previously (Huovilainen et al., , 1988 .
However, in other cases the pattern of antigenic change was more complicated, including opposite directions of population changes with regard to different MAbs. Thus, in the first specimen of AH, most of the strains were neutralized by MAbs 204 and 495, but not by 520 and 881 (Table 3) . Most of the strains in the two later specimens from AH showed the opposite pattern of neutralization; MAbs 520 and 881 were able to neutralize, whereas 204 and 495 were not. In one case (ME) one of the strains present in the first specimen had apparently overgrown the others and formed all 11 plaques obtained from the second specimen (Table 3 ).
The extent of the observed population changes was not directly proportional to the time between the analysed specimens, as in some cases (AH , Table 3 ) rather extensive changes were seen within 1 week, whereas in other cases (not shown) only very limited changes in the pattern were found between specimens taken 3 weeks apart.
Amino acid substitutions at and close to the known antigenic sites
Thirty-five strains representing different antigenic patterns were selected for partial sequencing of RNA at genomic regions coding for the major antigenic sites. Eight different sequences for the BC loop of VP1 at antigenic site 1 were represented in the population (Table 4) . MAbs 175, 204, 472, 495 and 520 are considered to be specific for this loop. None of these antibodies can neutralize the antigenically least common class of P3/Fin strains, which differ from Sabin 3 by having N instead of R at 1098 and another substitution at 1091, 1097, 1099 or 1100. Strains neutralized by MAb 175 had a KA, KV or NA substitution, rather than NV, at 1098 to 1099. However, strains with additional substitutions at 1091, 1097 or 1100 were resistant to MAb 175, despite NA at 1098 to 1099 (Table 4) . Strains differing from Sabin 3 only by K instead of R at 1098 were all neutralized by both MAb 175 and MAb 204, as well as by the other MAbs, to a variable extent. Minor et al. (1986) , is underlined. t +, Titre /> 16; -, titre <16. Finland/23127/84 strain according to Hughes et al. (1986) . § Sabin 3 according to Toyoda et al. (1984) and Stanway et al. (1983) . II yr, Not tested.
Neutralization by the other MAbs was not correlated with any specific substitution in this region of VP1. The region of RNA coding for the assumed binding site of MAb 881 was not sequenced.
Antigenic sites 2A and 2B showed, in general, much less variation than site 1 and the few substitutions seen (Table 5) did not correlate with neutralization by the only site 2-specific antibody used. No amino acid substitutions were found at or close to the antigenic site 3A (1286-KDGLA-1290). In contrast, antigenic site 3B again showed extensive variation, with 11 different sequences being represented (Table 6) .
MAb 842 raised against the P3/Fin/23127/87 strain (Magrath et al., 1986) neutralized three of the sequenced plaque-purified strains 1, 3 and 35. Strains 1 and 3 differed from all other strains at 3080. Strain 35 had the consensus D at 3080, but differed from all sequenced P3/ Fin strains by having D rather than N or K at 3077 (Table 6 ).
Silent mutations
In order to reveal the above amino acid substitutions lengths of RNA covering a total of 620 nucleotides were sequenced for the 35 plaque-purified strains. Apart from the mutations resulting in amino acid substitutions we also recorded silent mutations (Table 7) . No obvious difference in the frequency of occurrence of silent mutations was found between the five separate regions of genomic RNA sequenced, neither could we find any significant difference in the frequency of silent mutations between regions coding for antigenic sites and the rest of the sequenced RNA regions. The highest silent mutation rate between strains isolated from one person was 0-8 ~, which corresponds to a minimum of about 60 mutations per genome within a period of 3 weeks. The rate of occurrence of silent mutations between isolates from different people varied from 0 to 2.2~. Zero was recorded between strains LK 25 and AK 28, 29, 30, which were isolated from a mother and son, respectively. The highest mutual silent mutation rate was between strains SK 31 and PM 22, 23, 24, corresponding to about 160 mutations for the whole genome.
Specimens coded AH, RK, PM, LK, SK, ME and AK were all collected in one city in Southern Finland (Vantaa). Specimens labelled S J, on the other hand, were collected about 600 km north of Vantaa, although these strains did not differ in their extent of silent mutations from the Vantaa strains any more than they did from each other.
The percentages of total nucleotide differences in pairwise comparisons are also shown in Table 7 and, in most cases, the pattern resembles that of the silent nucleotide substitutions. 
Amino acid sequences at and near antigenic site 2A (VP1 ; 217-223) and 2B* (VP2 ; 164-172) of selected strains of type 3 poliovirus and neutralization pattern of the corresponding strain by MAb 882
Sequence subtype t AH 6, 7, 8, PM 20, 22, 23, 24, LK 25, 26, 27 (1986) . § Sabin 3 according to Toyoda et al. (1984) .
II Sabin 3 according to Stanway
et al. (1983) . ¶ NT, Not tested. tao b~ Table 6 . Amino acid sequence at and near antigenic site 3B * (VP3 ; [58] [59] [60] [70] [71] 77, [79] [80] Minor et al. (1986) , is underlined.
of selected strains of type 3 poliovirus and neutralization pattern of the corresponding strain by MAb 842
t +, Titre />16; -, titre <16.
:~ Finland/23127/84 strain according to Hughes et al. (1986) . § SJ 2, AH 4, RK 9, 10, 11, 12, 13, 14, 15, 16, 17, PM 19, 20, 22, 23, 24, LK 25, 26, 27, AK 28, ME 33, 34. II Sabin 3 according to Stanway et al. (1983) . SJ (3) AH (5) RK (9) PM (7) LK (3) SK (2) ME ( 2-6-3-0 1-7-2.5 2-0-2-8 2-2-3"2 1.7-2-0 0-5 1
* Sequenced regions covering a total of 620 nucleotides were compared and mutual differences between strains recorded. Number of strains tested for each person is shown in parentheses. Range of frequency of silent nucleotide differences is shown in the upper right-hand corner and that of total differences in the lower left-hand corner.
Discussion
In this study we have demonstrated that type 3 poliovirus populations in specimens collected during an outbreak in Finland in 1984 were genetically and antigenicaUy heterogeneous, probably because rapid evolution of the virus population took place in individual hosts. Immune selection seemed to drive the virus evolution, as antigenic variants were enriched during infection. The apparent direction of this phenotypic evolution, as judged by neutralization of the variants by a set of vaccine strain-specific MAbs, varied. RNA viruses are known to have high mutation frequencies coupled with high rates of replication. As a consequence of this, viral RNA populations have an extremely heterogeneous nature (Domingo et al., 1985; Steinhauer & Holland, 1987) . However, genetic heterogeneity does not automatically result in rapid evolution of the virus population. Under conditions where there are no selection mechanisms a virus strain can replicate for a long time with the same sequence predominating (Domingo et al., 1978) . The changing environment gives a competitive advantage to a more fit variant.
In this study we found that most poliovirus specimens consisted of antigenically distinct variants. The antigenic analysis was done directly from the primary microwell culture harvest of the end dilution step of our plaque purification method in order to maintain the variability existing in vivo as much as possible. Regular virus isolates from the respective faecal specimens did not always show the same neutralization pattern as the majority of the plaques purified directly from the specimen. This is obviously because variants resistant to a given MAb can, in the mixture, overgrow the sensitive ones during the several days incubation in the neutralization test (Huovilainen et al., 1988) . On the other hand, the regular isolates were tested after two passages in Vero cells, which may already have resulted in selection of some variants from the original mixture .
The distribution of different antigenic variants in sequential specimens varied strikingly in most cases. It is obvious that immune selection played an important role in these phenomena. We have previously reported the modifying role of intestinal host proteases in the selection phenomena, which can complicate the interpretation of the apparent neutralization patterns (Huovilainen et al., 1988; Minor et al., 1987) . The presence of different poliovirus variants in individual hosts could be due to transmission of virus mixtures from one host to another or, alternatively, generation of the variants in each individual from a homogeneous inoculum, or both. The first possibility cannot be excluded, but we believe that the second one is true since, in general, variation was greater between strains from different people than between those from one person. Furthermore, strains isolated from a given person often showed individual amino acid substitutions and/or silent mutations not seen in strains derived from other people (L. Kinnunen, unpublished) .
Partial RNA sequencing of genomic regions coding for the known antigenic sites revealed several patterns of amino acid substitutions at or close to the sites. In addition, some substitutions were seen at regions of the capsid proteins located more distantly from the known antigenic sites, but most of these substitutions were conservative in the sense that the type of amino acid was not changed. Some of the substitutions at antigenic site 1 could be correlated with an ability of MAbs 175 or 204 to neutralize the strain, whereas no simple correlation was obtained for MAbs 472, 497 and 520, which are all considered to be specific for antigenic site 1. This suggests that other components of capsid proteins, apart from the sequenced BC loop of VP1 contribute to the binding of these MAbs. Interestingly, no amino acid substitutions were seen at or close to the site 3A, whereas site 3B was as variable as site 1. Antigenic site 3A of the P3/Finland/84 strains differs strikingly from that of the two old American strains Leon/37 (Hughes et al., 1986) and Saukett/50 (Kinnunen & Hovi, 1989) , but not significantly from that of a number of more recently isolated Old World strains (T. P6yry et al., unpublished) . Silent mutation rates between different genes are approximately similar for all genes, even when amino acid-altering substitution rates are different (Kimura, 1981; Hayashida et al., 1985) . Amino acid substitution may result in selection against or in enrichment of the mutant, depending on the location of the mutation and on the environment. Silent mutations are neutral in this sense, irrespective of their location. The rate of occurrence of silent mutations in a partial sequence may thus give a relatively good estimate of the overall evolution potential of the virus genome.
There are no published data about natural silent mutation rates for polioviruses. Overall nucleotide substitution rates have been estimated using oligonucleotide mapping. Nottay et al. (1981) reported that the annual rate of nucleotide substitutions during an epidemic in an unvaccinated community was approximately 1 to 2~. In another publication the same group suggested that as many as 100 or more nucleotide substitutions were already fixed in the vaccine virus genome during an infection of one or two individuals. Our present data on silent mutation rates during natural type 3 poliovirus infection in individual hosts fit well with the latter figures. Sequential specimens collected from seven people with a 2 week interval showed a maximal rate of silent nucleotide substitutions of 0.5 ~o. This would correspond to about 30 to 40 silent nucleotide substitutions for the entire genome. The rate of silent nucleotide substitutions between specimens from different individuals was usually between 0.8 and 2~. The short duration of the outbreak made it impossible to study whether the number of silent mutations would have increased continuously for a longer period. Silent mutation rates for all influenza virus genes have been estimated to be approximately 0.6 to 1-4~o per nucleotide per year (Hayashida et al., 1985) . On the other hand, the in vitro mutation rate of the influenza A virus NS gene was reported to be greater than that of poliovirus VP1 (Parvin et al., 1986) .
The fact that the incidence of silent mutations was found to be close to the mutation rates estimated for the attenuated polioviruses indicates that the antigenic variability of the P3/Fin/84 strains during the outbreak was not due to an abnormally low fidelity of the RNA polymerase. This observation also supports the idea, but does not prove, that the well documented antigenic divergence of the P3/Fin/84 strains from the type 3 vaccine strains (Magrath et al., 1986; Hovi et al., 1986) was not due to a supposedly unusual variability of the epidemic strains, but may rather be a reflection of the natural existence of separate lineages (genotypes) of type 3 poliovirus, as previously reported for type 1 poliovirus (Rico-Hesse et al., 1987) .
